InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,780.35
(
-0.18%
)
Post# of 251715
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: xrymd post# 124435

Thursday, 08/04/2011 11:31:26 AM

Thursday, August 04, 2011 11:31:26 AM

Post# of 251715
There is actually a huge business opportunity here for a middleman to take on some of the risk. The middleman would evaluate patients and make a decision to guarantee payment based upon the patient profile. They guarantee to the doc they will pay if the MAC rejects the claim or delays payment.

Trick is I'm not sure some % of the $5800 provides enough money to create such a business. Not sure you could take a piece of DNDN's $93,000 for the service as your guarantee program could muck up the laws against DNDN doing this.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up